Tower Research Capital LLC (Trc) Xencor Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Xencor Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,630 shares of XNCR stock, worth $69,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,630
Previous 5,568
16.85%
Holding current value
$69,125
Previous $43,000
25.58%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding XNCR
# of Institutions
216Shares Held
81.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$166 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.7MShares$159 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.1MShares$106 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.22MShares$92.9 Million0.98% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$91.7 Million5.41% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $891M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...